IFNA1 and animal viral hepatitis: For example, when IFN-alpha was used in the treatment of viral hepatitis, its efficacy was diminished in alcohol-dependent patients; this was hypothesised to have been the result of ALD-mediated down-regulation of IFN-alpha signalling pathways, although anti-IFN antibodies have not been specifically sought in this setting [97].